Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis
Open Access
- 6 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Cancer
- Vol. 19 (1), 1-18
- https://doi.org/10.1186/s12943-020-01196-4
Abstract
Accumulating evidence suggests that circular RNAs (circRNAs) are important participants in cancer progression. However, the biological processes and underlying mechanisms of circRNAs in pancreatic ductal adenocarcinoma (PDAC) are unclear. CircRNAs were verified by Sanger sequencing. Colony formation, 5-Ethynyl-2′-deoxyuridine (EdU), and Transwell assays were performed to investigate the effect of circBFAR on the proliferation, invasion, and migration of PDAC cells in vitro. RNA pull-down assays were conducted to verify the binding of circBFAR with microRNA miR-34b-5p. In the present study, we identified a novel circRNA (termed as circBFAR, hsa_circ_0009065) that was upregulated in a 208-case cohort of patients with PDAC. The ectopic expression of circBFAR correlated positively with the tumor-node-metastasis (TNM) stage and was related to poorer prognosis of patients with PDAC. Moreover, circBFAR knockdown dramatically inhibited the proliferation and motility of PDAC cells in vitro and their tumor-promoting and metastasis properties in in vivo models. Mechanistically, circBFAR upregulated mesenchymal-epithelial transition factor (MET) expression via sponging miR-34b-5p. Additionally, circBFAR overexpression increased the expression of MET and activated downstream phosphorylation of Akt (Ser 473) and further activated the MET/PI3K/Akt signaling pathway, which ultimately promoted the progression of PDAC cells. Importantly, application of MET inhibitors could significantly attenuate circBFAR-mediated tumorigenesis in vivo. Our findings showed that circBFAR plays an important role in the proliferation and metastasis of PDAC, which might be explored as a potential prognostic marker and therapeutic target for PDAC.Keywords
Funding Information
- National Natural Science Foundation of China (81802530, 81871945, 81672495)
This publication has 49 references indexed in Scilit:
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNACancer Cell, 2016
- Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAsNature Communications, 2016
- Regulation of circRNA biogenesisRNA Biology, 2015
- Pancreatic AdenocarcinomaThe New England Journal of Medicine, 2014
- The p53/miR-34 axis in development and diseaseJournal of Molecular Cell Biology, 2014
- miR-34 Cooperates with p53 in Suppression of Prostate Cancer by Joint Regulation of Stem Cell CompartmentCell Reports, 2014
- Circular RNAs are a large class of animal RNAs with regulatory potencyNature, 2013
- Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine TumorsCancer Discovery, 2012
- Silencing of RON Receptor Signaling Promotes Apoptosis and Gemcitabine Sensitivity in Pancreatic CancersCancer Research, 2010
- The miR-34 family in cancer and apoptosisCell Death & Differentiation, 2009